Financial Performance

A 90-year-old family propane business is acquired by a PE-backed firm, signaling a major shift in the fragmented energy distribution market.

As Suunto marks 90 years with a retro-inspired watch, it navigates a fierce market, balancing its legacy of innovation with a new focus on sustainability.

A new triple-batch collection honors American history, pushing the boundaries of proof and collectibility for the coveted ultra-premium whiskey brand.

A new academic study offers a scientific framework for rating music, placing The Beatles at #1 and questioning the authority of iconic pop culture lists.

Award-winning Breckenridge Distillery partners with Romano Beverage, signaling a major push by parent company Tilray Brands into Illinois' key spirits market.

A new partnership with Restb.ai brings AI-powered image analysis and compliance checks directly into the NAVICA MLS, aiming to save agents time and improve data.

Cyber range leader SimSpace relocates to Orlando, joining Florida's integrated cyber ecosystem to tackle the AI-driven 'train-test gap' in security.

KLAS Research honors uPerform in a new award category, reflecting a critical industry shift where workforce training is now a core strategic priority.

With new revenue and client success chiefs, Gozio Health signals an aggressive push to scale its mobile platform and deliver tangible ROI to health systems.

Thousands, including minors, were secretly filmed in Northwell Health bathrooms. A new lawsuit exposes the breach and a year-long notification delay.

A new poll for America's 250th birthday shows a nation that reveres its Founders but has abandoned their core beliefs on rights and government.

With key data on its Duchenne muscular dystrophy drugs expected in 2026, Entrada's CEO Dipal Doshi will detail the firm's high-risk, high-reward strategy.

New 4-year real-world data shows Zevra's drug stabilizes the rare, fatal 'Childhood Alzheimer's' disease, marking a milestone for patients and families.

The firm's assets grew on market gains, but significant client outflows and shrinking fees triggered a sharp stock drop, revealing key industry pressures.

CDW announces a $0.630 quarterly dividend, marking 12 straight years of increases. Discover how its robust capital strategy fuels consistent investor returns.

With a key cancer drug awaiting FDA review and pivotal data imminent, Celcuity faces investors at a critical juncture. What will they be looking for?

With promising new pipeline data and a major earnings report looming, Aclaris Therapeutics heads to two investor summits, placing its strategy on display.

A major acquisition reshapes the shelf-stable food safety landscape, combining regulatory might with scientific expertise amid a booming market.

Fueled by strong investor demand, Meridian Mining has upsized its financing to C$50 million, accelerating its high-potential Cabaçal project in Brazil.

A new six-month injection for Central Precocious Puberty shows strong safety and efficacy, promising to ease the treatment burden for children and families.